retatrutide osteoarthritis for weight loss: Study shows 30% body weight loss Retatrutide: FDA approval time, trial

How reliable is it

Improved glycaemic control and cardiometabolic markers (e.g., inflammatory lipids and blood pressure reported in readouts)

Tesamorelin is a synthetic GHRH analogue licensed solely for HIV-associated lipodystrophy in the US and holds no MHRA authorisation for any indication in the UK

Read more Struggling with Zepbound side effects

The prevalence of weight-loss prescriptions in the active component increased from 1.2 per 100,000 service members in the first quarter of 2018 to 104.4 in the second quarter of 2023, a recent study by Medical Surveillance Monthly Report noted

There is also a lot of misinformation and hype about MTHFR, so this article sticks just to the high-quality studies on the topic